Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

6 Specialist management: needs and benefits

Identifieur interne : 002963 ( Main/Exploration ); précédent : 002962; suivant : 002964

6 Specialist management: needs and benefits

Auteurs : Gerold Stucki [Suisse]

Source :

RBID : ISTEX:4815048E77C543E0EDCD484256735BF2D1F2CA5E

English descriptors

Abstract

In increasingly cost-conscious, accountable and integrated health-care systems, the appropriate role of speciality care is under scrutiny. The data on the impact of rheumatologist care on outcomes in patients with rheumatoid arthritis (RA) is limited and inconclusive. However, based on a review of processes of care known to be related to superior patient outcomes it is suggested that rheumatologists should be the lead physicians in patients with RA. Rheumatologists but usually not generalists have the experience necessary to make an early diagnosis and to initiate appropriate disease modifying anti-rheumatic drug (DMARD) treatment. Rheumatologists have an in-depth understanding of new assessment methods to optimize medical treatment and to make best use of and co-ordinate multi-disciplinary care. To avoid delay of diagnosis and initiation of treatment, patients with polyarthritis should be referred to rheumatologists as soon as possible. This requires that access to rheumatologist care is guaranteed.

Url:
DOI: 10.1016/S0950-3579(97)80035-0


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">6 Specialist management: needs and benefits</title>
<author>
<name sortKey="Stucki, Gerold" sort="Stucki, Gerold" uniqKey="Stucki G" first="Gerold" last="Stucki">Gerold Stucki</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4815048E77C543E0EDCD484256735BF2D1F2CA5E</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0950-3579(97)80035-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-D2PH8D6R-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C77</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001C77</idno>
<idno type="wicri:Area/Istex/Curation">001C77</idno>
<idno type="wicri:Area/Istex/Checkpoint">001758</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001758</idno>
<idno type="wicri:Area/Main/Merge">002A13</idno>
<idno type="wicri:Area/Main/Curation">002963</idno>
<idno type="wicri:Area/Main/Exploration">002963</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">6 Specialist management: needs and benefits</title>
<author>
<name sortKey="Stucki, Gerold" sort="Stucki, Gerold" uniqKey="Stucki G" first="Gerold" last="Stucki">Gerold Stucki</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Rheumatology and Institute of Physical Medicine, University Hospital, Gloriastrasse 25, CH-8091 Zürich</wicri:regionArea>
<wicri:noRegion>CH-8091 Zürich</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="abbrev">BACR</title>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">11</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="97">97</biblScope>
<biblScope unit="page" to="107">107</biblScope>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>outcomes</term>
<term>quality management</term>
<term>rheumatoid arthritis</term>
<term>specialist</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute rheumatology service</term>
<term>Adverse effects</term>
<term>Appropriate disease</term>
<term>Appropriate role</term>
<term>Appropriate treatment</term>
<term>Arthritis</term>
<term>British journal</term>
<term>Chronic disease</term>
<term>Clinical status</term>
<term>Concepts result</term>
<term>Disease activity</term>
<term>Disease course</term>
<term>Dmard</term>
<term>Dmard therapy</term>
<term>Dmard treatment</term>
<term>General practitioners</term>
<term>Generalist</term>
<term>Health care</term>
<term>Health outcomes</term>
<term>Heijde dmfm</term>
<term>Important role</term>
<term>Internal medicine</term>
<term>Joint damage</term>
<term>Joint destruction</term>
<term>Medical care</term>
<term>Multidisciplinary</term>
<term>Multidisciplinary care</term>
<term>Optimal adjustment</term>
<term>Patient experience</term>
<term>Patient outcomes</term>
<term>Physical medicine</term>
<term>Physician specialty</term>
<term>Practice points</term>
<term>Primary care</term>
<term>Primary care centres</term>
<term>Primary care physicians</term>
<term>Primary physician care</term>
<term>Provider</term>
<term>Rheumatic</term>
<term>Rheumatic diseases</term>
<term>Rheumatism</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatologist</term>
<term>Rheumatologist care</term>
<term>Rheumatologists multidisciplinary care</term>
<term>Rheumatology</term>
<term>Riel plcm</term>
<term>Specialist care</term>
<term>Specialist management</term>
<term>Speciality</term>
<term>Speciality care</term>
<term>Standardized measures</term>
<term>Stucki</term>
<term>Studies show</term>
<term>Superior patient outcomes</term>
<term>Timely referral</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In increasingly cost-conscious, accountable and integrated health-care systems, the appropriate role of speciality care is under scrutiny. The data on the impact of rheumatologist care on outcomes in patients with rheumatoid arthritis (RA) is limited and inconclusive. However, based on a review of processes of care known to be related to superior patient outcomes it is suggested that rheumatologists should be the lead physicians in patients with RA. Rheumatologists but usually not generalists have the experience necessary to make an early diagnosis and to initiate appropriate disease modifying anti-rheumatic drug (DMARD) treatment. Rheumatologists have an in-depth understanding of new assessment methods to optimize medical treatment and to make best use of and co-ordinate multi-disciplinary care. To avoid delay of diagnosis and initiation of treatment, patients with polyarthritis should be referred to rheumatologists as soon as possible. This requires that access to rheumatologist care is guaranteed.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
</list>
<tree>
<country name="Suisse">
<noRegion>
<name sortKey="Stucki, Gerold" sort="Stucki, Gerold" uniqKey="Stucki G" first="Gerold" last="Stucki">Gerold Stucki</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002963 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002963 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4815048E77C543E0EDCD484256735BF2D1F2CA5E
   |texte=   6 Specialist management: needs and benefits
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021